NCT04854941View on ClinicalTrials.gov

Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection

NACompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

March 10, 2021

Study Completion Date

April 10, 2021

Conditions

Coronavirus Infection

Interventions

OTHER

Probiotics

Probiotics (10\^9 CFU of each strain: Lactobacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911 and Bifidobacterium longum PDV 2301) 3 times per day in addition to standard treatment regimen for 2 weeks

Trial Locations (1)

119991

I.M. Sechenov First Moscow State Medical University, Moscow

All Listed Sponsors

lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT04854941 - Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection | Biotech Hunter | Biotech Hunter